MediGene AG | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,209.00
5,195.00
3,101.00
4,101.00
7,676.00
7,576
Cost of Goods Sold (COGS) incl. D&A
2,486.00
2,896.00
2,045.00
2,246.00
2,820.00
2,381
Gross Income
1,723.00
2,299.00
1,056.00
1,855.00
4,856.00
5,195
SG&A Expense
13,387.00
12,973.00
15,202.00
20,719.00
21,944.00
23,198
EBIT
11,456.00
10,674.00
14,146.00
18,864.00
17,088.00
18,003
Unusual Expense
740.00
1,119.00
1,601.00
89.00
574.00
-
Non Operating Income/Expense
3,587.00
7,378.00
2,843.00
10,145.00
5,575.00
918
Interest Expense
1,577.00
1,468.00
1,367.00
1,217.00
1,126.00
139
Pretax Income
10,162.00
5,856.00
14,209.00
9,720.00
12,939.00
17,004
Income Tax
18.00
155.00
400.00
228.00
634.00
45
Equity in Affiliates
102.00
56.00
810.00
-
-
-
Consolidated Net Income
10,282.00
5,757.00
12,999.00
9,492.00
13,573.00
17,049
Net Income
10,282.00
5,757.00
12,999.00
9,492.00
13,573.00
17,049
Net Income After Extraordinaries
10,282.00
5,757.00
12,999.00
9,492.00
13,573.00
17,049
Net Income Available to Common
10,282.00
5,757.00
12,999.00
9,492.00
13,573.00
17,049
EPS (Basic)
1.07
0.47
0.77
0.48
0.63
0.72
Basic Shares Outstanding
9,631.60
12,210.90
16,808.50
19,952.70
21,501.10
23,669.20
EPS (Diluted)
1.07
0.47
0.77
0.48
0.63
0.72
Diluted Shares Outstanding
9,631.60
12,210.90
16,808.50
19,952.70
21,501.10
23,669.20
EBITDA
10,705.00
9,864.00
13,204.00
18,020.00
15,821.00
16,431
Other Operating Expense
208.00
-
-
-
-
-
Non-Operating Interest Income
24.00
27.00
62.00
305.00
274.00
220
About MediGene
View Profile
